Innovation Pharmaceuticals Inc. (IPIX: OTCQB) | Innovation Pharmaceuticals Announces Dosing of First Cohort in Phase 1 Trial of Oral Brilacidin in Ulcerative Colitis Program; Topline Results Anticipated Early Q1 2020

OTC Markets Group – News, Filings & Corporate Actions

Pin It